News & Updates

Show Multimedia Only

H-index predicts promotion in academic radiation oncology

12 May 2026

A recent study has found that a higher h-index is significantly associated with academic promotion among radiation oncologists.

H-index predicts promotion in academic radiation oncology

12 May 2026

First-line capivasertib-paclitaxel therapy misses survival target in metastatic TNBC

12 May 2026 by

Combination treatment with capivasertib and paclitaxel falls short of prolonging overall survival (OS) compared with placebo plus paclitaxel in patients with metastatic triple-negative breast cancer (TNBC), either in the overall or PIK3CA/AKT1/PTEN-altered populations, as shown in the CAPItello-290 trial

First-line capivasertib-paclitaxel therapy misses survival target in metastatic TNBC

12 May 2026

Auranofin-sirolimus combo delivers no antineoplastic activity in recurrent ovarian cancer

12 May 2026

Inhibition of the protein kinase C iota (PKCι) with auranofin and sirolimus does not provide antineoplastic effects in patients with recurrent high-grade serous ovarian cancer, reports a phase II study.

Auranofin-sirolimus combo delivers no antineoplastic activity in recurrent ovarian cancer

12 May 2026

Perioperative adebrelimab plus chemo: A new Tx option for resectable NSCLC?

12 May 2026 by

Perioperative adebrelimab plus chemotherapy improves event-free survival (EFS) and major pathological response (MPR) in individuals with resectable stage II/III non-small cell lung cancer (NSCLC) in an interim analysis.

Perioperative adebrelimab plus chemo: A new Tx option for resectable NSCLC?

12 May 2026

Combination of factors influence childhood food allergy risk

12 May 2026

A combination of early allergic conditions, delayed allergen introduction, genetics, antibiotic exposure, demographic factors, and birth-related variables factor in the development of food allergy in children, according to a meta-analysis.

Combination of factors influence childhood food allergy risk

12 May 2026

High-dose influenza vaccination reduces hospitalizations in older adults

12 May 2026 by

High-dose influenza vaccination is associated with a reduced risk of hospitalization for pneumonia or influenza in older adults, regardless of immunosuppression status, according to a prespecified pooled analysis of the FLUNITY-HD study presented at ESCMID Global 2026.

High-dose influenza vaccination reduces hospitalizations in older adults

12 May 2026

High remission rates in FLT3-ITD AML with quizartinib/omacetaxine combo

12 May 2026 by

Researchers from the University of Hong Kong found that therapy with the synergistic combination of quizartinib and omacetaxine mepesuccinate (QUIZOM) in acute myeloid leukaemia (AML) patients with FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutations produced high rates of composite complete remission (CRc), allowing more AML patients to be bridged to allogeneic haematopoietic stem cell transplantation (HSCT).

High remission rates in FLT3-ITD AML with quizartinib/omacetaxine combo

12 May 2026

Nitrofurantoin prevails in antibiotic showdown for uncomplicated UTI in women

11 May 2026 by

Nitrofurantoin performs better than single-dose fosfomycin in the treatment of uncomplicated urinary tract infections (UTIs) in women in the primary care setting, according to the SCOUT trial.